AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

The drug and vaccine maker is seeking to attract a broader investor base by leaning further toward the United States, where it generates almost half ...

British pharmaceutical group AstraZeneca said Thursday that it would invest $15 billion in China through 2030 to expand its ...

By Andrew MacAskill and Maggie Fick BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca will invest $15 billion in ...

AstraZeneca is showing no signs of restarting a 200 million pound sterling ($273 million) investment in its U.K. hometown, despite keeping its options open. | AstraZeneca is showing no signs of ...

Executives from Airbus, AstraZeneca and HSBC are joining Prime Minister Keir Starmer on a rare China visit, highlighting the ...

AstraZeneca has announced plans to invest $15 billion in China to pioneer the next-generation of innovative medicines. CEO ...

AstraZeneca PLC (NASDAQ: AZN) is one of the best healthcare stocks to buy for 2026. On January 29, AstraZeneca announced a ...

Europe hedges its bets as Starmer courts China, war tech backfires in Ukraine, AstraZeneca doubles down, and Denmark asserts ...

Drugs giant AstraZeneca has listed on the New York Stock Exchange, as it targets further global growth. The UK ...

AstraZeneca chief executive Pascal Soriot was part of a delegation of business leaders accompanying Starmer during the trip, ...